T. Wiersma

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 889 citations · Full text

Medicine, Immunology, Oncology +17

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study

Ariane A. van Loevezijn, Marieke E. M. van der Noordaa, Erik van Werkhoven et al. · Annals of Surgical Oncology · 2020 · 90 citations · Full text

Medicine, Oncology, Radiology +17

Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.

Marleen Kok, Leonie Voorwerk, Hugo M. Horlings et al. · Journal of Clinical Oncology · 2018 · 40 citations

Medicine, Immunology, Oncology +17

Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer

Tessa G. Steenbruggen, Michael Schaapveld, Hugo M. Horlings et al. · JNCI Cancer Spectrum · 2021 · 39 citations · Full text

Medicine, Biostatistics, Oncology +15

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

Marieke E. M. van der Noordaa, Frederieke van Duijnhoven, Claudette E. Loo et al. · The Breast · 2018 · 37 citations · Full text

Medicine, Oncology, Surgery +16